Schedule 13D ownership disclosure

IMMUNE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 45254C101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
32.5100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-14-012424
Form type
SC 13D
Filer
IMMUNE PHARMACEUTICALS INC
CIK
CIK 1208261
Filed
Jul 03, 2014
Reporting period
—
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub